Filters
Hikma launches authorised generic of Nucynta® ER (tapentadol) extended-release in the US
Press Release, Product
Hikma R&D. Innovation in formulation development. Meet Hamza Qassim
Story, Life at Hikma
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
Press Release, Financial Results
Hikma launches authorised generic of Nucynta® (tapentadol) in the US
Press Release, Product
New
Inspired at Hikma. Meet Ana Santos Perez
Story, Life at Hikma
Hikma R&D. Innovation in clinical research. Meet Hiba Kamal
Story, Life at Hikma
New
Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respect...
Press Release, Product
New
Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment
Press Release, Corporate
New
Exploring partnership opportunities with Hikma Pharmaceuticals. A Q&A with, Faisal Darwazeh VP of Group Business Develop...
Insight, Corporate
New
Hikma announces CEO change and Board appointment
Press Release, Corporate
New
Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy
Story, Leadership
New
European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada
Insight, Corporate
New
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Press Release, Product
New
Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables
Story, Leadership